A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...
WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more. How ...
In 1948, researchers stressed a nursing mother with ice water, toe pulling, and math problems with shocks. Each time, her baby got less milk. Thanksgiving 2026 Almanac Outlook Calls for Upper Midwest ...
The Pasadena Fire Department has joined a growing movement to provide life-saving blood transfusions at the scene of emergencies, using military-grade equipment. Fire Battalion Chief Chris Reno has a ...
Necrotizing enterocolitis (NEC) is a gastrointestinal (GI) disease in which sections of the bowel become inflamed and begin to die, creating a hole in the bowel. NEC occurs mostly in premature infants ...
Unfortunately, there is no known way to prevent ulcerative colitis (UC), which means some people may develop it, despite living a healthy lifestyle. Healthy lifestyle habits, such as exercising and ...
WASHINGTON (AP) — Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it’s far from clear how well it ...
Aaron Broverman is the Managing Editor of Forbes Advisor Canada. He has almost 20 years of experience writing in the personal finance space for outlets such as Bankrate, Bankrate Canada, ...
A key advisory committee that reviews medical devices for the Food and Drug Administration recommended the agency approve the first multi-cancer blood test for people 50 and over. Grail, the company ...
Advertising disclosure: When you use our links to explore or buy products we may earn a fee, but that in no way affects our editorial independence.
Advertising disclosure: When you use our links to explore or buy products we may earn a fee, but that in no way affects our editorial independence.